Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke.

MLA

Wang, Yanyun, et al. “Functionalized Nanoparticles with Monocyte Membranes and Rapamycin Achieve Synergistic Chemoimmunotherapy for Reperfusion-Induced Injury in Ischemic Stroke.” Journal of Nanobiotechnology, vol. 19, no. 1, Oct. 2021, p. 331. EBSCOhost, https://doi.org/10.1186/s12951-021-01067-0.

APA

Wang, Y., Wang, Y., Li, S., Cui, Y., Liang, X., Shan, J., Gu, W., Qiu, J., Li, Y., & Wang, G. (2021). Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke. Journal of Nanobiotechnology, 19(1), 331. https://doi.org/10.1186/s12951-021-01067-0

Chicago

Wang, Yanyun, Yi Wang, Shuyu Li, Yuliang Cui, Xiping Liang, Juanjuan Shan, Wei Gu, Juhui Qiu, Yiliang Li, and Guixue Wang. 2021. “Functionalized Nanoparticles with Monocyte Membranes and Rapamycin Achieve Synergistic Chemoimmunotherapy for Reperfusion-Induced Injury in Ischemic Stroke.” Journal of Nanobiotechnology 19 (1): 331. doi:10.1186/s12951-021-01067-0.